Diplomat Pharmacy (Diplomat Pharmacy) Cost of Goods Sold : $4,897 Mil (TTM As of Sep. 2019)

View and export this data going back to 2014. Start your Free Trial

What is Diplomat Pharmacy Cost of Goods Sold?

Diplomat Pharmacy's cost of goods sold for the three months ended in Sep. 2019 was $1,238 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Sep. 2019 was $4,897 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Diplomat Pharmacy's Gross Margin % for the three months ended in Sep. 2019 was 4.87%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Diplomat Pharmacy's Inventory Turnover for the three months ended in Sep. 2019 was 6.87.

Diplomat Pharmacy Cost of Goods Sold Historical Data

The historical data trend for Diplomat Pharmacy's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diplomat Pharmacy Cost of Goods Sold Chart

Diplomat Pharmacy Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Cost of Goods Sold

Get a 7-Day Free Trial

2,074.82

3,103.39

4,144.80

4,211.09

5,116.52

Diplomat Pharmacy Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Cost of Goods Sold	Get a 7-Day Free Trial															1,279.98	1,266.77	1,177.59	1,214.90	1,237.81

Diplomat Pharmacy Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,897 Mil.

Diplomat Pharmacy (NYSE:DPLO) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Diplomat Pharmacy's Gross Margin % for the three months ended in Sep. 2019 is calculated as:

Gross Margin %	=	(Revenue	-	Cost of Goods Sold)	/	Revenue
	=	(1301.197	-	1237.812)	/	1301.197
	=	4.87 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Diplomat Pharmacy's Inventory Turnover for the three months ended in Sep. 2019 is calculated as:

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1237.812	/	180.242
	=	6.87

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.

Diplomat Pharmacy Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Diplomat Pharmacy's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.

Diplomat Pharmacy (Diplomat Pharmacy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Diplomat Pharmacy Inc (NYSE:DPLO) » Definitions » Cost of Goods Sold

Traded in Other Exchanges

N/A

Address

4100 South Saginaw Street, Flint, MI, USA, 48507

Website

http://www.diplomat.is

Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.

Executives

Brian T Griffin	director, officer: Chairman and CEO
David C Dreyer	director	C/O SICOR INC, 19 HUGHES, IRVINE CA 92618-1902
Shawn Tomasello	director	C/O PHARMACYCLICS, INC, 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Regina M. Benjamin	director	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Benjamin Wolin	director	C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Jeffrey G Park	director	C/O DIPLOMAT PHARMACY, INC., 4100 S. SAGINAW ST., FLINT MI 48507
Sean Whelan	director, officer: Chief Financial Officer	C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Jeffrey M Rowe	director, officer: EVP of Operations	C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018